416 related articles for article (PubMed ID: 34304627)
1. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
4. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
Almalki AH; Alrowaie FA; Alhozali HM; Almalki NK; Alsubei AI; Alturki MS; Sadagah LF
Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
[TBL] [Abstract][Full Text] [Related]
5. Outcome of childhood lupus nephritis in Saudi children.
Al-Mayouf SM; AlAmeer A; Alfattani A; Alsonbul A
Saudi J Kidney Dis Transpl; 2017; 28(5):1015-1020. PubMed ID: 28937057
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
7. Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
Parodis I; Ding H; Zickert A; Cosson G; Fathima M; Grönwall C; Mohan C; Gunnarsson I
PLoS One; 2019; 14(2):e0212068. PubMed ID: 30742665
[TBL] [Abstract][Full Text] [Related]
8. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
[TBL] [Abstract][Full Text] [Related]
9. Long-term renal survival of paediatric patients with lupus nephritis.
Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
[TBL] [Abstract][Full Text] [Related]
10. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Hailu GT; Hussen SU; Getachew S; Berha AB
BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
[TBL] [Abstract][Full Text] [Related]
12. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S
Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993
[TBL] [Abstract][Full Text] [Related]
13. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
Yadav S; Balakrishnan C; Mangat G; Kothari J
Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588
[TBL] [Abstract][Full Text] [Related]
14. Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.
Hwang J; Kim HJ; Oh JM; Ahn JK; Lee YS; Lee J; Kim YG; Huh WS; Seo J; Koh EM; Cha HS
Rheumatol Int; 2012 Jul; 32(7):1877-84. PubMed ID: 21442173
[TBL] [Abstract][Full Text] [Related]
15. Presentation and outcome of pediatric lupus nephritis from a large single centre contemporary cohort in Eastern India.
Biswas D; Dasgupta D; Pal P; Sinha R
Lupus; 2023 Oct; 32(12):1440-1446. PubMed ID: 37707867
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
Yang TH; Wu TH; Chang YL; Liao HT; Hsu CC; Tsai CY; Chou YC
Clin Nephrol; 2018 Apr; 89(4):277-285. PubMed ID: 29319493
[TBL] [Abstract][Full Text] [Related]
17. Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.
Li C; Han Y; Zhang L; Chen Z; Jin M; Sun S
BMC Nephrol; 2022 Aug; 23(1):296. PubMed ID: 36008770
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis.
Das U; Patel R; Guditi S; Taduri G
Lupus; 2021 May; 30(6):876-883. PubMed ID: 33611965
[TBL] [Abstract][Full Text] [Related]
19. Early-stage predictors for treatment responses in patients with active lupus nephritis.
Liu G; Wang H; Le J; Lan L; Xu Y; Yang Y; Chen J; Han F
Lupus; 2019 Mar; 28(3):283-289. PubMed ID: 30682900
[TBL] [Abstract][Full Text] [Related]
20. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
